Ory, Benjamin <br/><br/>
Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  05 2016 
 - 2520-33 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-15-1925  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Diphosphonates--pharmacology<br/>Disease Progression<br/>Drug Synergism<br/>Female<br/>HSP90 Heat-Shock Proteins--metabolism<br/>Humans<br/>Imidazoles--pharmacology<br/>Mice<br/>Mice, Nude<br/>Monocytes--drug effects<br/>Neoplasm Metastasis--drug therapy<br/>Osteosarcoma--drug therapy<br/>Signal Transduction--drug effects<br/>Xenograft Model Antitumor Assays--methods<br/>Zoledronic Acid